MorphoSys AG buy Andal66
Start price
16.01.24
/
50%
€38.06
Target price
16.01.25
€45.00
Performance (%)
75.38%
Price
03.05.24
€66.75
Summary
This prediction is currently active. With a performance of 75.38% the BUY prediction by Andal66 is a big success. This prediction currently runs until 16.01.25. The prediction end date can be changed by Andal66 at any time. Andal66 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| MorphoSys AG | -1.476% | -1.476% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |